Loading...
UM School of Medicine Co-Led Novavax Vaccine Trial
Authors
Advisor
Date
2022-07-26
Embargo until
Language
Book title
Publisher
Peer Reviewed
Type
Article
Research Area
Jurisdiction
Collections
Other Titles
See at
Abstract
Data Availibility
Data / Code Location
Table of Contents
Description
The Centers for Disease Control and Prevention (CDC) this week recommended a new COVID-19 protein-based vaccine as an option for primary vaccination of adults aged 18 and older. The University of Maryland School of Medicine’s (UMSOM) Karen Kotloff, MD, professor of pediatrics, medicine, epidemiology, and public health, co-led the multi-center PREVENT-19 clinical trial, which studied the safety and efficacy of the Novavax vaccine in about 30,000 adult study participants.
Citations
Altmetric: